← All companies

AURX

Nuo Therapeutics, Inc.

AURX OTC Surgical & Medical Instruments & Apparatus EDGAR ↗

$1.00

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$48.4M

Revenue (TTM)

$4.13M

Net income (TTM)

-$2.38M

EPS (TTM)

$-0.04

P/E ratio

—

Dividend yield

8250000.00%

Free cash flow

-$1.14M

Cash

$264K

Total assets

$1.95M

Gross margin

65.5%

52-week range

$0.84 – $3.23

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 3, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 26, 2026 8-K Shareholder vote results Dec 17, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Director or officer change; Item 5.08; Other events Oct 10, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Entered a material agreement May 15, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Apr 1, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Unregistered sale of equity Sep 19, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Other events Jun 27, 2024 8-K Changed accountants Jun 11, 2024 8-K Entered a material agreement; Unregistered sale of equity May 21, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 19, 2024 8-K Regulation FD disclosure Apr 16, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 20, 2023 10-Q Quarter ended 2023-09-30 Nov 20, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Entered a material agreement; Unregistered sale of equity Aug 3, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K/A Fiscal year ended 2022-12-31 Apr 18, 2023 10-K Fiscal year ended 2022-12-31 Apr 17, 2023 8-K Shareholder vote results Dec 5, 2022 10-Q Quarter ended 2022-09-30 Nov 4, 2022 10-Q Quarter ended 2021-09-30 Nov 4, 2022 8-K Item 5.08; Other events Sep 30, 2022 8-K Entered a material agreement; Regulation FD disclosure Aug 30, 2022 10-Q/A Quarter ended 2022-06-30 Aug 10, 2022 10-Q Quarter ended 2022-06-30 Aug 8, 2022 8-K Other events Jun 28, 2022 10-Q Quarter ended 2022-03-31 May 16, 2022 8-K Entered a material agreement; Unregistered sale of equity May 2, 2022 10-K Fiscal year ended 2021-12-31 Apr 15, 2022 8-K Entered a material agreement; Unregistered sale of equity Jan 4, 2022